Healthcare Realty Trust Incorporated (HR)
After hours:
| Previous Close | 14.38 |
| Open | 14.28 |
| Bid | 0.00 x 1400 |
| Ask | 15.20 x 1800 |
| Day's Range | 13.94 - 14.36 |
| 52 Week Range | 12.77 - 20.32 |
| Volume | |
| Avg. Volume | 3,499,298 |
| Market Cap | 5.416B |
| Beta (5Y Monthly) | 0.66 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.24 (8.84%) |
| Ex-Dividend Date | Feb 23, 2024 |
| 1y Target Est | N/A |
- GlobeNewswire
Healthcare Realty Trust Announces First Quarter Earnings Release Date and Conference Call
NASHVILLE, Tenn., April 17, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that it expects to report results for the first quarter of 2024 on Tuesday morning, May 7, 2024, before the market opens. On Tuesday, May 7, 2024, at 12:00 p.m. (Noon) Eastern Time, Healthcare Realty Trust expects to hold a conference call to discuss earnings results, quarterly activities, general operations of the Company and industry trends. Simultaneously, a webcast of the confe
- GlobeNewswire
Healthcare Realty Trust Announces Planned Retirement of Two Directors and 2024 Nominees
NASHVILLE, Tenn., March 04, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced the nomination of 11 of its current 13 directors to stand for election to its Board of Directors at the Company’s annual meeting of stockholders to be held on May 21, 2024. The Board has also fixed its size at 11 directors pursuant to the authority granted under the Company’s bylaws. Current directors W. Bradley Blair, II, Vice Chairman, and Edward H. Braman will be retiring from s
- GlobeNewswire
Healthcare Realty Trust Reports Results for the Fourth Quarter
NASHVILLE, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the fourth quarter ended December 31, 2023. The Company reported net income (loss) attributable to common stockholders of $(40.5) million, or $(0.11) per diluted common share, for the quarter ended December 31, 2023. Normalized FFO for the three months ended December 31, 2023 totaled $150.7 million, or $0.39 per diluted common share. The following applies to all same sto
